Recent evidence suggests that VEGF has therapeutic potential as a neuroprotective factor in many neurological diseases [12,15], such as stroke [16,17,18], epilepsy [14,19], and neurodegenerative diseases [12,20,21,22]. The gene discussed is VEGFA; the disease is neurodegenerative disease.